M.I. Epidemiological aspects of pneumococcal meningitis in the Russian Federation


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. To assess the relevance of the problem associated with pneumococcal meningitis (PCM) in the Russian Federation during the period 2010-2018 and to determine the serotypic characteristics of pneumococcal strains. Materials and methods. Data were collected in accordance with Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being (RFSSCRPHW) letter No. 01/9620-0-32 «On the interaction of territorial RFSSCRPHW bodies with the Reference Center for Bacterial Meningitis Monitoring» dated June 29, 2010. A total of 123pneumococcal strains isolated from the cerebrospinal fluid or blood of PCM patients were studied in 2014 to 2017. Results. The incidence of PCM tends to increase in the Russian Federation. The highest incidence rates were found in a group of children less than 5 years of age. The highest mortality rates in the study period were noted in a group of people over 45 years of age; the maximum (25%) rate was recorded among people aged over 65 years in 2018. The correspondence of invasive pneumococcal strains to the serotypes included in the PCV13 vaccine was 70%. Conclusion. It is necessary to continue a close epidemiological surveillance of PCM and to expand the coverage of immunization with conjugated pneumococcal vaccines in children and adults of the Russian Federation.

Full Text

Restricted Access

About the authors

Irina S. Koroleva

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: irina-korol@yandex.ru

Grigiriy V. Beloshitsky

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: g-belosh1@yandex.ru

Maria A. Koroleva

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: korolevamaria389@gmail.com

Maria I. Gritsai

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: maria-griz@mail.ru

References

  1. Zunt J.R., Kassebaum N.J., Blake N., Glennie L., Wright C., Nichols E. et al. Global, regional, and national burden of meningitis, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018; 17(12): 1061-82. doi: 10.1016/S1474-4422(18)30387-9.
  2. Wahl B., O’Brien K.L., Greenbaum A., Majumder A., Liu L., Chu Y. et al. Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000-15. Lancet Glob. Health. 2018; 6(7): e744-e57. doi: 10.1016/S2214-109X(19)30081-6.
  3. Izurieta P., Bahety P., Adegbola R., Clarke C., Hoet B. Public health impact of pneumococcal conjugate vaccine infant immunization programs: assessment of invasive pneumococcal disease burden and serotype distribution. Expert Rev. Vaccines 2018; 17(6): 47993. https://doi.org/10.1080/14760584.2018. 1413354
  4. Edmond K., Clark A., Korczak V.S., Sanderson C., Griffiths U.K., Rudan I. Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and metaanalysis. Lancet Infect. Dis. 2010; 10(5): 317-28. doi: 10.1016/ S1473-3099(10)70048-7.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies